Life Science Deals and Alliances of Jan-Mar 2014

FOR IMMEDIATE RELEASE, Illinois – United States – May 2,2014 (PR Buzz): Life Science Deals and Alliances of Jan-Mar 2014 is a new market research publication announced by Reportstack. A review of partnering trends and comprehensive directory of life science deals and alliances announced during Q1, 2014

A review of life science partnering trends and comprehensive directory of deals and alliances announced during Jan to Mar or Q1, 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past quarter of the year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The report provides an overview of the trends in dealmaking during Q1, 2014 covering trends by deal type, stage of development, technology type and therapeutic indication, a review of the leading deals during Q1, 2014. Deals are listed by headline value and most active companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract,  a comprehensive directory of all partnering deals announced during 2013. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during Q1, 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during Q1, 2014.

Key benefits

Life Science Deals and Alliances of Jan-Mar 2014 provides the reader with the following key benefits:

In-depth understanding of recent dealmaking trends during Q1, 2014  
Comprehensive access to all  deals entered into by the world’s life science companies during Q1, 2014
Detailed access to actual partnership and M&A deals and contracts entered into by the leading companies
Understand the key deal terms companies have agreed in previous deals         
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Life Science Deals and Alliances of Jan-Mar 2014 is intended to provide the reader with an in-depth understanding and access to parthering and M&A trends and structure of deals entered into by leading companies worldwide.

Life Science Deals and Alliances of Jan-Mar 2014 includes:

Trends in dealmaking in the bigbiotech industry during Q1, 2014
Analysis of partnering and M&A deal structure
Comprehensive directory of partnering and M&A deals in Q1, 2014
Links to online access to all deals and alliances
The leading partnering and M&A deals by value in Q1, 2014
Most active partnering and M&A dealmakers during Q1, 2014

In Life Science Deals and Alliances of Jan-Mar 2014 series the partnering and M&A deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Therapy area
Technology type

Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.

Companies Mentioned
Abbott 
Actavis
Allergan
Amgen
Astellas
AstraZeneca
Baxter
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly 
Endo
Forest
Fresenius
Galderma 
Gilead Sciences
GlaxoSmithKline 
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co 
Merck KGaA 
Mitsubishi Tanabe
Mylan
Novartis 
Novo Nordisk
Otsuka
Pfizer
Purdue
Ranbaxy 
Roche 
Sanofi
Servier
Shionogi
Shire 
Stada 
Takeda
Teva
UCB view
Valeant
Warner Chilcott 

To view the table of contents and know more details please visit Life Science Deals and Alliances of Jan-Mar 2014 report.